KR102587176B1 - 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 - Google Patents

혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 Download PDF

Info

Publication number
KR102587176B1
KR102587176B1 KR1020227013227A KR20227013227A KR102587176B1 KR 102587176 B1 KR102587176 B1 KR 102587176B1 KR 1020227013227 A KR1020227013227 A KR 1020227013227A KR 20227013227 A KR20227013227 A KR 20227013227A KR 102587176 B1 KR102587176 B1 KR 102587176B1
Authority
KR
South Korea
Prior art keywords
delete delete
methylation
plasma
dna
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020227013227A
Other languages
English (en)
Korean (ko)
Other versions
KR20220065034A (ko
Inventor
로사 와이 퀀 치우
콴 치 찬
유크 밍 데니스 로
미우 판 룬
페이용 지앙
와이 만 찬
Original Assignee
더 차이니즈 유니버시티 오브 홍콩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102587176(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by 더 차이니즈 유니버시티 오브 홍콩 filed Critical 더 차이니즈 유니버시티 오브 홍콩
Priority to KR1020237033920A priority Critical patent/KR20230145530A/ko
Publication of KR20220065034A publication Critical patent/KR20220065034A/ko
Application granted granted Critical
Publication of KR102587176B1 publication Critical patent/KR102587176B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
KR1020227013227A 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 Active KR102587176B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237033920A KR20230145530A (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US61/703,512 2012-09-20
US13/842,209 2013-03-15
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
US61/830,571 2013-06-03
KR1020217030373A KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
PCT/AU2013/001088 WO2014043763A1 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of fetus or tumor from plasma

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020217030373A Division KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020237033920A Division KR20230145530A (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Publications (2)

Publication Number Publication Date
KR20220065034A KR20220065034A (ko) 2022-05-19
KR102587176B1 true KR102587176B1 (ko) 2023-10-06

Family

ID=50340462

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020207019527A Active KR102307424B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020217030373A Active KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020157010184A Active KR102148547B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020237033920A Ceased KR20230145530A (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020227013227A Active KR102587176B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Family Applications Before (4)

Application Number Title Priority Date Filing Date
KR1020207019527A Active KR102307424B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020217030373A Active KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020157010184A Active KR102148547B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020237033920A Ceased KR20230145530A (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Country Status (28)

Country Link
EP (6) EP4056712B1 (enExample)
JP (6) JP6317354B2 (enExample)
KR (5) KR102307424B1 (enExample)
CN (2) CN104781422B (enExample)
AU (5) AU2013317708C1 (enExample)
BR (3) BR122021021825B1 (enExample)
CA (2) CA2884066C (enExample)
CY (1) CY1124139T1 (enExample)
DK (4) DK4056712T3 (enExample)
EA (1) EA201500327A1 (enExample)
ES (4) ES2969567T3 (enExample)
FI (2) FI3536807T3 (enExample)
HR (3) HRP20241142T1 (enExample)
HU (3) HUE068129T2 (enExample)
IL (4) IL299444B2 (enExample)
LT (2) LT3354747T (enExample)
MX (1) MX360034B (enExample)
MY (2) MY173356A (enExample)
NZ (2) NZ706269A (enExample)
PH (2) PH12022552061A1 (enExample)
PL (4) PL3536807T3 (enExample)
PT (4) PT3354747T (enExample)
SG (2) SG10201705198UA (enExample)
SI (1) SI4056712T1 (enExample)
SM (1) SMT202100256T1 (enExample)
TW (4) TWI707953B (enExample)
WO (1) WO2014043763A1 (enExample)
ZA (1) ZA201501772B (enExample)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
LT3354747T (lt) * 2012-09-20 2021-04-12 The Chinese University Of Hong Kong Neinvazinis naviko metilomos nustatymas iš plazmos
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3029148B1 (en) * 2013-07-30 2018-06-27 BGI Genomics Co., Limited Method for determining nucleic acid composition of nucleic acid mixture
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
US12054771B2 (en) * 2014-02-18 2024-08-06 Bionano Genomics, Inc. Methods of determining nucleic acid structural information
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
EP3957749A1 (en) * 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
CN107223159A (zh) 2014-05-09 2017-09-29 科戴克斯生命股份公司 源自特定细胞类型的dna的检测及相关方法
TWI895765B (zh) * 2014-07-18 2025-09-01 香港中文大學 Dna混合物中之組織甲基化模式分析
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
KR102696857B1 (ko) 2014-07-25 2024-08-19 유니버시티 오브 워싱톤 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법
GB2552267B (en) * 2014-12-31 2020-06-10 Guardant Health Inc Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
CA2976303A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
CN108138233B (zh) 2015-07-20 2022-08-26 香港中文大学 Dna混合物中组织的单倍型的甲基化模式分析
HUE057821T2 (hu) 2015-07-23 2022-06-28 Univ Hong Kong Chinese Sejtmentes DNS fragmentációs mintázatának elemzése
IL285795B (en) 2015-08-12 2022-07-01 Univ Hong Kong Chinese Single-molecule sequencing of plasma dna
US10457990B2 (en) 2015-09-22 2019-10-29 The Chinese University Of Hong Kong Accurate deduction of fetal DNA fraction with shallow-depth sequencing of maternal plasma
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
CN108368548A (zh) * 2015-11-09 2018-08-03 普罗格尼迪公司 用于确定dna分子的来源的方法
EP3168309B8 (en) 2015-11-10 2020-06-03 Eurofins LifeCodexx GmbH Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female
AU2016370835B2 (en) * 2015-12-17 2020-02-13 Illumina, Inc. Distinguishing methylation levels in complex biological samples
EP3411505A4 (en) * 2016-02-02 2020-01-15 Guardant Health, Inc. EVIDENCE OF CANCER DEVELOPMENT AND DIAGNOSTICS
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
EP4425178A3 (en) * 2016-05-03 2024-12-18 University Health Network Methods of capturing cell-free methylated dna and uses of same
US12300356B2 (en) 2016-05-04 2025-05-13 Queen's University At Kingston Cell-free detection of methylated tumour DNA
EP3885447B1 (en) * 2016-05-30 2024-01-10 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free dna in blood
EP3472358B1 (en) * 2016-06-16 2021-08-18 The Johns Hopkins University Methods and system for epigenetic analysis
CN107779485B (zh) 2016-08-24 2022-03-18 中国科学院分子细胞科学卓越创新中心 Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用
US11512306B2 (en) 2016-10-19 2022-11-29 The Chinese University Of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma DNA
EP3535415A4 (en) 2016-10-24 2020-07-01 The Chinese University of Hong Kong TUMOR DETECTION METHODS AND SYSTEMS
IL315032A (en) 2016-11-30 2024-10-01 Univ Hong Kong Chinese Analysis of cell-free dna in urine and other samples
ES2983411T3 (es) * 2016-12-13 2024-10-23 Bellwether Bio Inc Determinación de un estado fisiológico en un individuo analizando los puntos finales de fragmentos de ADN libre de células en una muestra biológica
US20200255896A1 (en) * 2017-01-11 2020-08-13 Quest Diagnostics Investments Llc Method for non-invasive prenatal screening for aneuploidy
CN110191964B (zh) * 2017-01-24 2023-12-05 深圳华大基因股份有限公司 确定生物样本中预定来源的游离核酸比例的方法及装置
CA3051509A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
CA3063405A1 (en) * 2017-05-12 2018-11-15 President And Fellows Of Harvard College Universal early cancer diagnostics
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
CA3069754A1 (en) * 2017-07-12 2019-01-17 University Health Network Cancer detection and classification using methylome analysis
CA3069668A1 (en) * 2017-07-12 2019-01-17 Ande Corporation Pattern recognition system
JP7776099B2 (ja) 2017-07-26 2025-11-26 ザ チャイニーズ ユニバーシティー オブ ホンコン 無細胞ウイルス核酸を用いる癌スクリーニングの強化
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
EP4269583A3 (en) 2017-09-28 2024-01-17 Grail, LLC Enrichment of short nucleic acid fragments in sequencing library preparation
US11168356B2 (en) * 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
WO2019178277A1 (en) 2018-03-13 2019-09-19 Grail, Inc. Anomalous fragment detection and classification
CN112534506B (zh) * 2018-03-15 2025-03-04 格瑞尔公司 组织特异性的甲基化标志物
DE202019005627U1 (de) 2018-04-02 2021-05-31 Grail, Inc. Methylierungsmarker und gezielte Methylierungssondenpanels
SG11202009696WA (en) * 2018-04-13 2020-10-29 Freenome Holdings Inc Machine learning implementation for multi-analyte assay of biological samples
CN112218957B (zh) * 2018-04-16 2025-08-08 格里尔公司 用于确定在无细胞核酸中的肿瘤分数的系统及方法
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
AU2019351130B2 (en) 2018-09-27 2025-10-23 GRAIL, Inc Methylation markers and targeted methylation probe panel
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
GB2595076B8 (en) 2018-11-21 2023-08-23 Agilent Technologies Inc Methods for targeted nucleic acid library formation
TW202536188A (zh) * 2018-12-19 2025-09-16 香港中文大學 游離dna末端特徵
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
CA3127894A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
TWI874374B (zh) 2019-03-25 2025-03-01 香港中文大學 確定循環核酸之線性及環狀形式
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
AU2020268885A1 (en) * 2019-05-03 2021-12-02 Cornell University Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
EP4020484A4 (en) * 2019-08-19 2023-08-30 Green Cross Genome Corporation METHOD FOR DETECTING A CHROMOSOME ABNORMALITY USING INFORMATION CONCERNING THE DISTANCE BETWEEN NUCLEIC ACID FRAGMENTS
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
WO2021108654A1 (en) * 2019-11-27 2021-06-03 Grail, Inc. Systems and methods for evaluating longitudinal biological feature data
KR20220133984A (ko) 2020-01-31 2022-10-05 아비다 바이오메드 인코포레이티드 표적화된 핵산 캡쳐를 위한 시스템 및 방법
EP4103740A1 (en) * 2020-02-10 2022-12-21 Palogen, Inc. Nanopore device and methods of detecting and classifying charged particles using same
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
CA3169488A1 (en) * 2020-02-28 2021-09-02 Collin MELTON Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
CA3202240A1 (en) * 2020-11-19 2022-05-27 Nucleix Ltd. Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencing
WO2022133315A1 (en) * 2020-12-17 2022-06-23 President And Fellows Of Harvard College Methods of cancer detection using extraembryonically methylated cpg islands
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
EP4409468A4 (en) * 2021-09-28 2025-08-13 Act Genomics Ip Ltd APPARATUS AND METHODS FOR SELECTING METHYLATION BIOMARKERS
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
CN118215743A (zh) * 2021-11-04 2024-06-18 通用诊断股份公司 用于制备用于基因测序的生物样品的系统和方法
IL317918A (en) 2022-02-07 2025-02-01 Centre For Novostics Fragmentation for measuring mitotic and disease
WO2023164017A2 (en) * 2022-02-22 2023-08-31 Flagship Pioneering Innovations Vi, Llc Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN118737268A (zh) * 2023-05-04 2024-10-01 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒的数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011141711A1 (en) 2010-05-12 2011-11-17 Aberystwyth University Methods for selecting methylation markers

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
DK1342794T3 (da) 2002-03-05 2006-04-24 Epigenomics Ag Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
EP1570081A4 (en) * 2002-11-19 2006-05-31 Amgen Inc AMPLIFIED GENES INVOLVED IN CANCER
US20060183128A1 (en) 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
EP2290106B1 (en) * 2004-03-08 2018-01-03 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
AU2006251937A1 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating DNA for diagnosis, prognosis, and treatment of cancer
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) * 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
CN101153336B (zh) * 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
KR102222378B1 (ko) 2007-07-23 2021-03-04 더 차이니즈 유니버시티 오브 홍콩 핵산 서열 불균형의 결정
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
CA2775671A1 (en) * 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
HUE061110T2 (hu) * 2009-11-05 2023-05-28 Univ Hong Kong Chinese Magzati genomelemzés anyai biológiai mintából
WO2011054936A1 (en) 2009-11-06 2011-05-12 The Chinese University Of Hong Kong Size-based genomic analysis
EP2513341B1 (en) * 2010-01-19 2017-04-12 Verinata Health, Inc Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
AU2011210255B2 (en) * 2010-01-26 2014-11-20 Medicover Public Co Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
CA3007713C (en) 2010-04-29 2020-05-26 The Regents Of The University Of California Pathway recognition algorithm using data integration on genomic models (paradigm)
DK2576832T3 (en) 2010-05-25 2016-06-20 Univ Johns Hopkins CONFIGURATIONS AND METHODS FOR DETECTION OF neoplasia
KR20130041961A (ko) * 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
SG186787A1 (en) * 2010-07-23 2013-02-28 Esoterix Genetic Lab Llc Identification of differentially represented fetal or maternal genomic regions and uses thereof
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
KR101891847B1 (ko) 2010-11-30 2018-08-24 더 차이니즈 유니버시티 오브 홍콩 암과 연관된 유전적 또는 분자적 이상들의 검출
LT3354747T (lt) * 2012-09-20 2021-04-12 The Chinese University Of Hong Kong Neinvazinis naviko metilomos nustatymas iš plazmos

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011141711A1 (en) 2010-05-12 2011-11-17 Aberystwyth University Methods for selecting methylation markers

Also Published As

Publication number Publication date
NZ706269A (en) 2016-08-26
LT4056712T (lt) 2024-09-10
SI4056712T1 (sl) 2024-10-30
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
KR20230145530A (ko) 2023-10-17
EP2898100A4 (en) 2016-05-11
EP2898100B2 (en) 2023-05-10
PL4056712T3 (pl) 2024-12-02
KR20200085928A (ko) 2020-07-15
HRP20241142T1 (hr) 2024-11-22
TW202334438A (zh) 2023-09-01
IL268512B2 (en) 2023-06-01
EP2898100A1 (en) 2015-07-29
TW202043483A (zh) 2020-12-01
BR112015006183A2 (pt) 2017-07-04
HRP20210716T1 (hr) 2021-06-11
NZ717423A (en) 2017-08-25
EP4335929A3 (en) 2024-05-29
JP2025026936A (ja) 2025-02-26
EP3536807B1 (en) 2023-11-29
HK1206797A1 (en) 2016-01-15
KR20220065034A (ko) 2022-05-19
AU2022201026A1 (en) 2022-03-10
KR20210120124A (ko) 2021-10-06
MY187444A (en) 2021-09-22
CA2884066A1 (en) 2014-03-27
CY1124139T1 (el) 2022-05-27
KR102307424B1 (ko) 2021-09-29
HK1257868A1 (en) 2019-11-01
HUE068129T2 (hu) 2024-12-28
EP4056712A1 (en) 2022-09-14
JP2015536639A (ja) 2015-12-24
EP4056712B1 (en) 2024-07-31
DK3536807T3 (da) 2024-02-05
TWI806621B (zh) 2023-06-21
IL237495A0 (en) 2015-04-30
PL3536807T3 (pl) 2024-05-06
EA201500327A1 (ru) 2015-07-30
AU2013317708B2 (en) 2017-08-03
EP3354747B1 (en) 2021-02-17
TW201907013A (zh) 2019-02-16
PT2898100T (pt) 2018-02-26
JP6985753B2 (ja) 2021-12-22
JP2024009833A (ja) 2024-01-23
BR112015006183B1 (pt) 2022-04-26
AU2017251832A1 (en) 2017-11-16
BR122021021823B1 (pt) 2023-04-25
SG11201501927VA (en) 2015-04-29
CN117757932A (zh) 2024-03-26
JP2022031753A (ja) 2022-02-22
IL299444A (en) 2023-02-01
CN104781422A (zh) 2015-07-15
DK3354747T3 (da) 2021-04-19
FI4056712T3 (fi) 2024-08-29
HUE053822T2 (hu) 2021-07-28
AU2022201026B2 (en) 2025-04-03
EP3354747A1 (en) 2018-08-01
EP3839065A1 (en) 2021-06-23
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
TW201418474A (zh) 2014-05-16
LT3354747T (lt) 2021-04-12
AU2017251832B2 (en) 2019-10-10
EP4335929A2 (en) 2024-03-13
ES2665273T5 (es) 2023-10-02
JP7594817B2 (ja) 2024-12-05
MX360034B (es) 2018-10-19
TWI640634B (zh) 2018-11-11
FI3536807T3 (fi) 2024-02-01
HK1207124A1 (en) 2016-01-22
CN104781422B (zh) 2023-12-26
SG10201705198UA (en) 2017-07-28
AU2020200128A1 (en) 2020-01-30
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
ES2862726T3 (es) 2021-10-07
MY173356A (en) 2020-01-21
KR20150082228A (ko) 2015-07-15
MX2015003571A (es) 2015-06-22
EP2898100B9 (en) 2023-08-02
PL2898100T5 (pl) 2023-11-06
TWI784258B (zh) 2022-11-21
EP2898100B1 (en) 2017-11-22
AU2013317708A1 (en) 2015-04-09
IL313451A (en) 2024-08-01
ES2994426T3 (en) 2025-01-23
WO2014043763A1 (en) 2014-03-27
JP6683752B2 (ja) 2020-04-22
PH12015500547B1 (en) 2024-05-17
BR122021021825B1 (pt) 2022-05-24
PL2898100T3 (pl) 2018-06-29
JP6317354B2 (ja) 2018-04-25
DK4056712T3 (da) 2024-08-26
CA2884066C (en) 2021-08-10
SMT202100256T1 (it) 2021-05-07
CA3122779A1 (en) 2014-03-27
PT3536807T (pt) 2024-02-01
ES2665273T3 (es) 2018-04-25
AU2025205087A1 (en) 2025-07-24
PL3354747T3 (pl) 2021-07-26
TWI707953B (zh) 2020-10-21
ZA201501772B (en) 2016-10-26
JP2020108400A (ja) 2020-07-16
ES2969567T3 (es) 2024-05-21
AU2020200128B2 (en) 2021-11-18
DK2898100T3 (en) 2018-02-26
IL268512A (en) 2019-09-26
IL237495B (en) 2019-09-26
HRP20240210T1 (hr) 2024-05-10
HUE066054T2 (hu) 2024-07-28
IL299444B2 (en) 2024-11-01
TW202305145A (zh) 2023-02-01
JP2018121644A (ja) 2018-08-09
DK2898100T4 (da) 2023-07-24
PH12015500547A1 (en) 2015-05-04
KR102148547B1 (ko) 2020-08-26
AU2013317708C1 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
JP7594817B2 (ja) 血漿による胎児または腫瘍のメチロームの非侵襲的決定
US20250349386A1 (en) Non-invasive detection of tissue abnormality using methylation
TWI901957B (zh) 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
HK40075963B (en) Non-invasive determination of methylome of tumor from plasma
HK40075963A (en) Non-invasive determination of methylome of tumor from plasma
HK40055436A (en) Non-invasive determination of methylome of tumor from plasma
HK40013800B (en) Non-invasive determination of methylome of tumor from plasma
HK40013800A (en) Non-invasive determination of methylome of tumor from plasma
HK1257868B (en) Non-invasive determination of methylome of tumor from plasma
HK1207124B (zh) 从血浆无创测定胎儿或肿瘤的甲基化组
HK1206797B (en) Non-invasive determination of methylome of fetus or tumor from plasma

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220420

Application number text: 1020217030373

Filing date: 20210923

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220506

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20221222

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230703

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20231004

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20231004

End annual number: 3

Start annual number: 1

PG1601 Publication of registration